Literature DB >> 29632955

In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.

Takashi Kajiya1, Hiroshi Yamaguchi2, Junichiro Takaoka1, Kengo Fukunaga1, Ryoichi Arima1, Akihiro Miyamura1, Toshiko Ninomiya1, Nobuhiko Atsuchi1, Yoshihiko Atsuchi1, Mitsuyasu Terashima3, Hideaki Kaneda4, Mitsuru Ohishi5.   

Abstract

INTRODUCTION: The pathophysiology and mechanism of in-stent restenosis (ISR) after implantation of second-generation drug-eluting stents (DESs) are not fully clear. We compared the morphological characteristics of ISR between first- and second-generation DESs using frequency domain optical coherence tomography (OCT).
METHODS: Patients who underwent follow-up coronary angiography (CAG) after first-generation (CYPHER™ and TAXUS™) and second-generation (Nobori®, PROMUS Element™, Resolute Integrity and XIENCE) DES implantations were examined. ISR was defined as lesions of over 50% diameter stenosis at follow-up CAG. Frequency domain OCT was performed at the time of revascularisation of ISR. Tissue morphology was assessed at minimum lumen area. OCT images of DESs at both early (≤ 1 year) and late (> 1 year) phase follow-up were compared.
RESULTS: On qualitative OCT assessment, the ratios of homogeneous, layered, heterogeneous without-attenuation and heterogeneous with-attenuation morphologies were 57.1%, 17.1%, 20.0% and 5.7%, respectively, for second-generation DES ISR (n = 35), and 16.7%, 25.0%, 25.0% and 33.3%, respectively, for first-generation DES ISR (n = 36). At late phase follow-up, homogeneous morphology was significantly more common for second-generation DES ISR compared to first-generation DES ISR (first-generation: 8.0% vs. second-generation: 50.0%; p < 0.01) while heterogeneous with-attenuation morphology was significantly more common for first-generation DES ISR (first-generation: 44.0% vs. second-generation: 5.6%; p < 0.01).
CONCLUSION: Homogeneous tissue morphology was more frequently found for second-generation than first-generation DES ISR, especially in the late phase. This suggested that neointimal hyperplasia was the main mechanism in second-generation DES ISR, and that the neointima was stabilised, much like in bare metal stent implantation. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  DES; drug-eluting stent; optical coherence tomography

Mesh:

Substances:

Year:  2018        PMID: 29632955      PMCID: PMC6351689          DOI: 10.11622/smedj.2018038

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  14 in total

1.  Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.

Authors:  Takeshi Tada; Kazushige Kadota; Shingo Hosogi; Koshi Miyake; Hideo Amano; Michitaka Nakamura; Yu Izawa; Shunsuke Kubo; Tahei Ichinohe; Yusuke Hyoudou; Haruki Eguchi; Yuki Hayakawa; Suguru Otsuru; Daiji Hasegawa; Yoshikazu Shigemoto; Seiji Habara; Hiroyuki Tanaka; Yasushi Fuku; Harumi Kato; Tsuyoshi Goto; Kazuaki Mitsudo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-09-15       Impact factor: 6.875

2.  Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.

Authors:  Ryo Arikawa; Hiroshi Yamaguchi; Junichiro Takaoka; Akihiro Miyamura; Nobuhiko Atsuchi; Toshiko Ninomiya; Yoshihiko Atsuchi; Mitsuru Ohishi; Mitsuyasu Terashima; Hideaki Kaneda
Journal:  Cardiovasc Revasc Med       Date:  2014-11-20

3.  Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation - An Optical Coherence Tomography Study.

Authors:  Hiroyuki Jinnouchi; Shoichi Kuramitsu; Tomohiro Shinozaki; Yusuke Tomoi; Takashi Hiromasa; Yohei Kobayashi; Takenori Domei; Yoshimitsu Soga; Makoto Hyodo; Shinichi Shirai; Kenji Ando
Journal:  Circ J       Date:  2017-01-27       Impact factor: 2.993

Review 4.  Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice.

Authors:  Masataka Nakano; Renu Virmani
Journal:  Cardiovasc Interv Ther       Date:  2014-07-30

Review 5.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Authors:  Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

6.  Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials.

Authors:  Philippe Généreux; David R Rutledge; Tullio Palmerini; Adriano Caixeta; Elvin Kedhi; James B Hermiller; Jin Wang; Mitchell W Krucoff; Jennifer Jones-McMeans; Krishnankutty Sudhir; Charles A Simonton; Patrick W Serruys; Gregg W Stone
Journal:  Circ Cardiovasc Interv       Date:  2015-05       Impact factor: 6.546

7.  Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.

Authors:  Marco A Magalhaes; Sa'ar Minha; Fang Chen; Rebecca Torguson; Al Fazir Omar; Joshua P Loh; Ricardo O Escarcega; Michael J Lipinski; Nevin C Baker; Hironori Kitabata; Hideaki Ota; William O Suddath; Lowell F Satler; Augusto D Pichard; Ron Waksman
Journal:  Circ Cardiovasc Interv       Date:  2014-12-02       Impact factor: 6.546

8.  Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.

Authors:  Hiroshi Yamaguchi; Ryo Arikawa; Junichiro Takaoka; Akihiro Miyamura; Nobuhiko Atsuchi; Toshiko Ninomiya; Yoshihiko Atsuchi; Mitsuru Ohishi; Mitsuyasu Terashima; Hideaki Kaneda
Journal:  Cardiovasc Revasc Med       Date:  2014-12-23

9.  Optical coherence tomography patterns of stent restenosis.

Authors:  Nieves Gonzalo; Patrick W Serruys; Takayuki Okamura; Heleen M van Beusekom; Hector M Garcia-Garcia; Gijs van Soest; Wim van der Giessen; Evelyn Regar
Journal:  Am Heart J       Date:  2009-08       Impact factor: 4.749

10.  Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy.

Authors:  Masao Imai; Takeshi Kimura; Takeshi Morimoto; Naritatsu Saito; Hiroki Shiomi; Ren Kawaguchi; Hakuken Kan; Hiroaki Mukawa; Hiroshi Fujita; Takuo Ishise; Fujio Hayashi; Kazuya Nagao; Shunsuke Take; Hiromasa Taniguchi; Hiroki Sakamoto; Takafumi Yamane; Kinya Shirota; Hiromichi Tamekiyo; Takayuki Okamura; Koichi Kishi; Shinichirou Miyazaki; Satoshi Yamamoto; Kyohei Yamaji; Tomohiro Kawasaki; Eiji Taguchi; Hitoshi Nakajima; Ippei Kosedo; Takeshi Tada; Kazushige Kadota; Kazuaki Mitsudo
Journal:  Cardiovasc Interv Ther       Date:  2014-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.